52 North Health - creators of NeutroCheck Revenue and Competitors
Estimated Revenue & Valuation
- 52 North Health - creators of NeutroCheck's estimated annual revenue is currently $3.5M per year.
- 52 North Health - creators of NeutroCheck's estimated revenue per employee is $167,619
- 52 North Health - creators of NeutroCheck's total funding is $8M.
Employee Data
- 52 North Health - creators of NeutroCheck has 21 Employees.
- 52 North Health - creators of NeutroCheck grew their employee count by 40% last year.
52 North Health - creators of NeutroCheck's People
| Name | Title | Email/Phone |
|---|---|---|
1 | CEO & Co-Founder | Reveal Email/Phone |
2 | Chief Digital Officer | Reveal Email/Phone |
3 | Chief Scientific and Medical Officer | Reveal Email/Phone |
4 | Head Product Development | Reveal Email/Phone |
5 | Head Operations | Reveal Email/Phone |
6 | Head Digital Development | Reveal Email/Phone |
52 North Health - creators of NeutroCheck Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $3.5M | 21 | 40% | $8.19M | N/A |
What Is 52 North Health - creators of NeutroCheck?
Our vision is to improve health outcomes and health equity by reinventing care pathways for all people across the world. We do this by developing fully-integrated clinical, AI and medical-device based systems to improve healthcare delivery and quality of life. We create affordable technologies that empower people and enable decentralised clinical decision-making. We prioritise human-centred design and engage with people living with disease throughout our product life-cycle to reinvent their healthcare journeys.
keywords:N/A
$8M
Total Funding
21
Number of Employees
$3.5M
Revenue (est)
40%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Other Companies in Cambridge
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $8.5M | 21 | -78% | $305.9M |
#2 | $2.1M | 21 | -16% | N/A |
#3 | $4.8M | 21 | N/A | N/A |
#4 | $1.5M | 21 | -47% | N/A |
#5 | $2.6M | 21 | 31% | N/A |